Joint Juice names CEO
SAN FRANCISCO Joint Juice earlier this week named David Ritterbush the company’s new CEO. Ritterbush, who makes the transition from COO, has been with the joint health nutrition company since 2009.
"As chief operating officer, David has proven his ability as a strong and motivating leader with a clear understanding of the benefits and opportunities for Joint Juice," stated Joint Juice board member Mark Slezak. "[His] impressive industry knowledge and experience will undoubtedly position Joint Juice for further brand growth and expansion."
With more than 20 years of experience in the consumer packaged goods industry, Ritterbush began his career with Dreyer’s Grand Ice Cream. Over the span of his tenure with the organization, Dreyer’s grew from a $300 million company to a $2 billion company.
Most recently, Ritterbush was VP and general manager for Red Bull North America, the leading global energy drink company, where he was responsible for all distribution, marketing and sales in the western United States.
FDA tentatively approves generic Crestor
MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries.
Sun announced Wednesday the tentative approval of rosuvastatin calcium tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths.
The drug is a generic version of AstraZeneca’s Crestor, which had annual sales of around $3.4 billion in the United States, according to Sun. Sun did not disclose when it would begin marketing its version of the drug, though Crestor will lose patent protection for use in adults in December 2021, according to FDA data.
Walgreens kicks off nationwide safe medication-disposal program
DEERFIELD, Ill. Walgreens has teamed up with Sharps Compliance to launch the drug store chain’s first-ever safe medication-disposal program.
Walgreens said the program is designed to protect public safety, as well as ease the concern of parents that fear children and teens can access unused medications at home. The company has kicked off this program with the help of Sharps Compliance, a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications, which estimated that more than 200 million lbs. of unused dispensed medications are disposed of improperly each year.
How it works: For $2.99, customers can purchase a specially designed envelope — postage cost included — available at any Walgreens pharmacy counter that allows them to place, seal and mail prescription or over-the-counter medications they no longer use for safe, eco-friendly disposal. Controlled substances are excluded from the program, Walgreens said.
“In thousands of communities, Walgreens serves as the most accessible source of everyday health information,” said Walgreens VP pharmacy operations Richard Ashworth. “That makes us a natural choice for guidance on anything involving medications, including proper disposal. Through this program, we can do our part to keep expired or unused medications out of waterways and out of the hands of those who could be accidentally harmed.”